Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen’s AGE1.CR Vaccine Manufacturing Platform
ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative...
COVID-19 Vaccine Access To All Is Nothing More Than A Myth
As per Amnesty International, both Pharma companies, as well as wealthy states of the world, have failed miserably to ensure that everyone has equal...
For Low Survival Breast Cancers, Australia Pumps-In $5.5 M
In a development that gives a big sigh of relief to the breast cancer fraternity, funding of a couple of clinical trials which could...
Piramal Pharma Solutions Bloats In-Vitro Bio Potential
Piramal Pharma Solutions has confirmed that it has put in a multi-million dollar investment to create a top-notch screening facility that will elevate the...
WuXi STA’s Shanghai Facility Gets FDA Nod Post Inspection
WuXi AppTec’s WuXi STA has said that its facility at Waigaoqiao near Shanghai has cleared its first FDA drug product pre-approval inspection. Notably, the...
Indian Pharma Industry To Grow By 9-11% In FY22- ICRA
Driven by the push from emerging as well as domestic markets in the upcoming quarters, the Indian Pharma industry in the Financial Year-22 is...
WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site
WuXi STA – a subsidiary of WuXi AppTec, announced that its Waigaoqiao site in Shanghai, China, successfully passed the first drug product pre-approval inspection...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...